Filters: Keyword is Treatment Outcome [Clear All Filters]
"Efficacy of a brief HIV prevention counseling intervention among STI clinic patients in Russia: a randomized controlled trial." AIDS and behavior 17, no. 3 (2013): 1016-24. Abstract
"DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions." Archives of internal medicine 170, no. 1 (2010): 109-10.
"Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S376-87. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S178-83. Abstract
"Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45, no. 6 (2007): 770-8. Abstract
"The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand." Vaccine 29, no. 36 (2011): 6092-9. Abstract
"The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results." Vaccine 29, no. 36 (2011): 6107-12. Abstract
"A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization." Drug and alcohol dependence 112, no. 3 (2010): 178-93. Abstract
"Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine." Drug and alcohol dependence 134 (2014): 106-14. Abstract
"Patient satisfaction with primary care office-based buprenorphine/naloxone treatment." Journal of general internal medicine 22, no. 2 (2007): 242-5. Abstract
"Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana." BMC infectious diseases 13 (2013): 476. Abstract
"Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone." Journal of addiction medicine 6, no. 4 (2012): 274-9. Abstract
"Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want?" Journal of addiction medicine 5, no. 3 (2011): 181-7. Abstract
"Cost and utilization outcomes of opioid-dependence treatments." The American journal of managed care 17 Suppl 8 (2011): S235-48. Abstract
"Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?" Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48, no. 6 (2009): 822-6. Abstract
"Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies." AIDS (London, England) 21, no. 12 (2007): 1579-89. Abstract
"Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?" Journal of the International AIDS Society 14 (2011): 38. Abstract
"Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?" Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 13, no. 5 (2010): 535-42. Abstract
"The marketing of methadone: how an effective medication became unpopular." The International journal on drug policy 24, no. 6 (2013): e89-90.
"Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone." Drug and alcohol dependence 105, no. 3 (2009): 234-9. Abstract
"Medical interventions for addictions in the primary care setting." Topics in HIV medicine : a publication of the International AIDS Society, USA 18, no. 1 (2010): 8-12. Abstract
"Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16, no. 8 (2012): 998-1004. Abstract
"Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents." AIDS care 24, no. 9 (2012): 1092-6. Abstract
"Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8." The Journal of infectious diseases 191, no. 3 (2005): 324-32. Abstract
"Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms." Journal of substance abuse treatment 29, no. 4 (2005): 307-12. Abstract
"Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail." AIDS and behavior 17 Suppl 2 (2013): S118-27. Abstract
"First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial." AIDS (London, England) 25, no. 4 (2011): 479-92. Abstract
"The Veterans Aging Cohort Study: observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus-infected veterans." Alcoholism, clinical and experimental research 28, no. 2 (2004): 313-21. Abstract
"Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence." The American journal of drug and alcohol abuse 33, no. 5 (2007): 643-54. Abstract
"Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy." Journal of substance abuse treatment 31, no. 2 (2006): 163-71. Abstract
"Brief intervention for hazardous and harmful drinkers in the emergency department." Annals of emergency medicine 51, no. 6 (2008): 742-750.e2. Abstract
"A novel approach to prevention for at-risk HIV-negative men who have sex with men: creating a teachable moment to promote informed sexual decision-making." American journal of public health 101, no. 3 (2011): 539-45. Abstract
"HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment." Journal of addiction medicine 7, no. 6 (2013): 410-6. Abstract
"Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir." AIDS patient care and STDs 26, no. 6 (2012): 312-9. Abstract
"Predictors of short-term recovery differ from those of long-term outcome after arthroscopic partial meniscectomy." Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 24, no. 7 (2008): 769-78. Abstract
"A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 23, no. 4 (2002): 233-44. Abstract
"Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 2 (2002): 111-23. Abstract
"Opioid dependence: rationale for and efficacy of existing and new treatments." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S173-7. Abstract
"Treatment of heroin dependence with buprenorphine in primary care." The American journal of drug and alcohol abuse 28, no. 2 (2002): 231-41. Abstract
"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
"Substance use of disorders in HIV-infected patients: impact and new treatment strategies." Topics in HIV medicine : a publication of the International AIDS Society, USA 12, no. 3 (2004): 77-82. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies." The Journal of infectious diseases 196 Suppl 1 (2007): S114-23. Abstract
"Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV." The Journal of antimicrobial chemotherapy 58, no. 6 (2006): 1299-302. Abstract
"Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma." Pediatrics 118, no. 2 (2006): e347-55. Abstract
"Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density." The Journal of allergy and clinical immunology 117, no. 2 (2006): 359-66. Abstract
"Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance." AIDS (London, England) 22, no. 1 (2008): 75-82. Abstract
"Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America." AIDS (London, England) 26, no. 11 (2012): 1415-23. Abstract
